Published in Dis Esophagus on March 06, 2009
Squamous Cell Carcinoma - Similarities and Differences among Anatomical Sites. Am J Cancer Res (2011) 1.13
Expression of epidermal growth factor receptor is an independent prognostic factor for esophageal squamous cell carcinoma. World J Surg Oncol (2013) 0.92
A panel of overexpressed proteins for prognosis in esophageal squamous cell carcinoma. PLoS One (2014) 0.92
Cyclooxygenase isoenzyme-2 and vascular endothelial growth factor are associated with poor prognosis in esophageal adenocarcinoma. J Gastrointest Surg (2012) 0.86
A pilot study of nimotuzumab combined with cisplatin and 5-FU in patients with advanced esophageal squamous cell carcinoma. J Thorac Dis (2012) 0.85
Probing the link between oestrogen receptors and oesophageal cancer. World J Surg Oncol (2010) 0.84
Laboratory animal models for esophageal cancer. Vet World (2016) 0.81
Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J Natl Cancer Inst (2001) 4.27
Efficacy of 'radioguided occult lesion localisation' (ROLL) versus 'wire-guided localisation' (WGL) in breast conserving surgery for non-palpable breast cancer: a randomised controlled multicentre trial. Breast Cancer Res Treat (2012) 3.99
Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. J Pathol (2001) 3.94
Systematic review of five feeding routes after pancreatoduodenectomy. Br J Surg (2013) 3.40
Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol (2000) 3.20
Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1). J Pathol (2005) 2.70
Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent. Int J Cancer (1993) 2.60
Doxorubicin gradients in human breast cancer. Clin Cancer Res (1999) 2.36
Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns. J Pathol (2001) 2.33
Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer. J Clin Pathol (2005) 2.10
Radioactive seed localization for non-palpable breast cancer. Br J Surg (2013) 2.07
Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations. Gynecol Oncol (2000) 2.04
Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg (1998) 2.02
Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients. Eur J Cancer (2004) 2.00
Reduced local immune response with continuous positive airway pressure during one-lung ventilation for oesophagectomy. Br J Anaesth (2014) 1.98
Relationships between vascularization and proliferation in invasive breast cancer. J Pathol (1999) 1.90
Nature meets nurture: molecular genetics of gastric cancer. Hum Genet (2009) 1.87
Activated cytotoxic T cells as prognostic marker in Hodgkin's disease. Blood (1997) 1.82
Learning to perform endoscopic resection of esophageal neoplasia is associated with significant complications even within a structured training program. Endoscopy (2011) 1.82
[The sentinel node procedure: standard intervention for surgical treatment of breast cancer]. Ned Tijdschr Geneeskd (1998) 1.76
Heterogeneity and reproducibility of microvessel counts in breast cancer. Lab Invest (1995) 1.75
Systematic review of innovative ablative therapies for the treatment of locally advanced pancreatic cancer. Br J Surg (2014) 1.75
Goblet cell carcinoid of the appendix: a specific type of carcinoma. Histopathology (2007) 1.73
Interstitial laser coagulation for hepatic tumours. Br J Surg (1999) 1.68
First experience with robot-assisted thoracoscopic esophagolymphadenectomy for esophageal cancer. Surg Endosc (2006) 1.67
Peritoneal changes due to laparoscopic surgery. Surg Endosc (2010) 1.67
Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops. J Pathol (1998) 1.62
Expression of differentiation and proliferation related proteins in epithelium of prophylactically removed ovaries from women with a hereditary female adnexal cancer predisposition. Histopathology (2003) 1.59
Interlaboratory reproducibility of semiautomated cell cycle analysis of flow cytometry DNA-histograms obtained from fresh material of 1,295 breast cancer cases. Hum Pathol (1996) 1.58
Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis. J Pathol (1998) 1.58
The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2alpha. Oncogene (2007) 1.57
Comparative genomic hybridisation. Mol Pathol (1999) 1.56
Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation. J Clin Pathol (1998) 1.54
Sulindac targets nuclear beta-catenin accumulation and Wnt signalling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell lines. Br J Cancer (2004) 1.54
Impaired healing of cutaneous wounds and colonic anastomoses in mice lacking thrombin-activatable fibrinolysis inhibitor. J Thromb Haemost (2003) 1.52
Clinical and genetic evaluation of thirty ovarian cancer families. Am J Obstet Gynecol (1998) 1.49
Extended neoadjuvant chemotherapy in locally advanced breast cancer combined with GM-CSF: effect on tumour-draining lymph node dendritic cells. Eur J Cancer (2003) 1.48
Hypoxia-inducible factor-1alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer. Histopathology (2005) 1.47
Endoscopic ablation therapy for Barrett's esophagus with high-grade dysplasia: a review. Am J Gastroenterol (1999) 1.45
Transhiatal robot-assisted esophagectomy. Surg Endosc (2008) 1.44
Representation of the elderly in trials of laparoscopic surgery for colorectal cancer. Colorectal Dis (2014) 1.43
Mucosal prolapse in the pathogenesis of Peutz-Jeghers polyposis. Gut (2006) 1.42
In-transit lymph node metastases in breast cancer: a possible source of local recurrence after Sentinel Node procedure. J Clin Pathol (2008) 1.42
Effects of tirapazamine on experimental colorectal liver metastases after radiofrequency ablation. Br J Surg (2012) 1.42
[The surgical treatment of nonpalpable breast carcinoma in a university teaching hospital and a general teaching hospital by residents-in-training and surgeons; comparable results]. Ned Tijdschr Geneeskd (2004) 1.42
Impactitis: new cures for an old disease. J Clin Pathol (2001) 1.42
Histopathology of fibroadenoma of the breast. Am J Clin Pathol (2001) 1.41
Large genomic deletions of SMAD4, BMPR1A and PTEN in juvenile polyposis. Gut (2008) 1.41
[Increased perioperative blood loss during treatment with paroxetine]. Ned Tijdschr Geneeskd (2002) 1.40
DNA profiling of primary serous ovarian and fallopian tube carcinomas with array comparative genomic hybridization and multiplex ligation-dependent probe amplification. J Pathol (2007) 1.40
Quality control methods for data entry in pathology using a computerized data management system based on an extended data dictionary. Hum Pathol (1992) 1.38
[MRI-guided biopsy of suspicious abnormalities in the breast]. Ned Tijdschr Geneeskd (2006) 1.38
[Primary adenocarcinoma of the small intestine]. Ned Tijdschr Geneeskd (2003) 1.37
Predictors for neoplastic progression in patients with Barrett's Esophagus: a prospective cohort study. Am J Gastroenterol (2011) 1.36
Robot-assisted thoracoscopic oesophagectomy for cancer. Br J Surg (2009) 1.36
Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review. Eur J Surg Oncol (2005) 1.35
Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer. Arch Surg (2001) 1.34
Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast. Mol Pathol (2000) 1.34
Mouse models of colorectal cancer and liver metastases. Dig Surg (2005) 1.33
Primary extranodal non-Hodgkin lymphoma of the oral cavity. An analysis of 34 cases. Eur J Cancer B Oral Oncol (1994) 1.31
Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach. J Clin Pathol (1999) 1.28
Functional lymphatic anatomy for sentinel node biopsy in breast cancer: echoes from the past and the periareolar blue method. Ann Surg (2000) 1.27
Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution. J Pathol (2001) 1.26
Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med (1997) 1.25
The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma. Cancer (2001) 1.25
Histopathological workup of sentinel lymph nodes: how much is enough? J Clin Pathol (1999) 1.25
Lack of lymphangiogenesis during breast carcinogenesis. J Clin Pathol (2004) 1.25
Vacuum-assisted breast biopsy: a critical review. Eur J Cancer (2003) 1.24
Distinction between hereditary and sporadic breast cancer on the basis of clinicopathological data. J Clin Pathol (2006) 1.24
Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer. Br J Cancer (1998) 1.23
Molecular imaging of breast cancer. Breast (2009) 1.22
Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet-derived endothelial cell growth factor, and proliferation markers in colorectal cancer. Clin Cancer Res (2000) 1.21
'Radioguided occult lesion localisation' (ROLL) for non-palpable breast lesions: a review of the relevant literature. Eur J Surg Oncol (2007) 1.21
Ultrasound-guided laser-induced thermal therapy for small palpable invasive breast carcinomas: a feasibility study. Ann Surg Oncol (2009) 1.20
Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET - randomised controlled trial. Eur J Cancer (2010) 1.19
Interplay between VHL/HIF1alpha and Wnt/beta-catenin pathways during colorectal tumorigenesis. Oncogene (2006) 1.17
Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases. Am J Pathol (2000) 1.16
Sentinel node investigation in breast cancer: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol (2001) 1.16
European survey on the application of vascular clamping in liver surgery. Dig Surg (2007) 1.14
Comparative proteomics of colon cancer stem cells and differentiated tumor cells identifies BIRC6 as a potential therapeutic target. Mol Cell Proteomics (2011) 1.14
Current technologies for HER2 testing in breast cancer. Crit Rev Oncol Hematol (2011) 1.14
5-Aminolaevulinic acid-induced protoporphyrin IX accumulation in tissues: pharmacokinetics after oral or intravenous administration. J Photochem Photobiol B (1998) 1.14
Prognostic relevance of P-glycoprotein expression in breast cancer. Ann Oncol (1995) 1.13
Methylation is less abundant in BRCA1-associated compared with sporadic breast cancer. Ann Oncol (2008) 1.12
Diagnosis of breast lesions: fine-needle aspiration cytology or core needle biopsy? A review. J Clin Pathol (2011) 1.12
Sentinel lymph node biopsy of the internal mammary chain in breast cancer. Breast Cancer Res Treat (2012) 1.10
Hot spot microvessel density and the mitotic activity index are strong additional prognostic indicators in invasive breast cancer. Histopathology (2000) 1.10
Radiofrequency ablation and endoscopic resection in a single session for Barrett's esophagus containing early neoplasia: a feasibility study. Endoscopy (2012) 1.10
Histopathology of retrieved allografts of the femoral head. J Bone Joint Surg Br (1999) 1.10
Effects of chemotherapy on pathologic and biologic characteristics of locally advanced breast cancer. Am J Clin Pathol (1997) 1.10